SCHEMBL18933721

SCHEMBL18933721

Nc1nnc(NC2CCN(c3ccc(F)nn3)C2)s1

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GLS O94925 20/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18890107 1.00 GLS (0.58) GLS
SCHEMBL18951919 0.87 GLS (0.59) GLS
SCHEMBL18890098 0.87 GLS (0.59) GLS
SCHEMBL18915210 0.83 GLS (0.58) GLS
SCHEMBL18933614 0.81 GLS (0.61) GLS
SCHEMBL17309177 0.81 GLS (0.61) GLS
SCHEMBL17654115 0.77 GLS (0.61) GLS
SCHEMBL17664538 0.77 GLS (0.61) GLS
SCHEMBL19434609 0.77 GLS (0.61) GLS
SCHEMBL17309281 0.76 GLS (0.55) GLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3383871-B1 1,3,4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2019-09-11 — — EP disclosed
WO-2017093299-A1 1,3,4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2017-06-08 — — WO disclosed
Send feedback